IMNN insider trading — Imunon, Inc.
Over the last 90 days, insiders at Imunon, Inc. (IMNN) made 0 open-market purchases worth $0 and 4 open-market sales worth $16K, making them net sellers by $16K. The largest sale was by Eylward Susan (General Counsel and Corp Sec), who sold 2,449 shares for $4K on Aug 17, 2026.
Updated Oct 16, 2026.
Recent IMNN insider transactions
Every Form 4 filed by Imunon, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 7,800 | $1.08 | $8K | Form 4 |
| Oct 9, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 2,977 | $1.08 | $3K | Form 4 |
| Oct 9, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 1,249 | $1.08 | $1K | Form 4 |
| Sep 25, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 7,169 | $1.41 | $10K | Form 4 |
| Sep 25, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 6,697 | $1.41 | $9K | Form 4 |
| Sep 25, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 4,390 | $1.41 | $6K | Form 4 |
| Sep 11, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 5,824 | $1.47 | $9K | Form 4 |
| Sep 11, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 5,504 | $1.47 | $8K | Form 4 |
| Sep 11, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 4,211 | $1.47 | $6K | Form 4 |
| Aug 28, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 7,371 | $1.60 | $12K | Form 4 |
| Aug 28, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 6,822 | $1.60 | $11K | Form 4 |
| Aug 28, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 3,626 | $1.60 | $6K | Form 4 |
| Aug 31, 2026 | Eylward Susan | General Counsel and Corp Sec | S · Sale | Direct | 2,525 | $1.56 | $4K | Form 4 |
| Aug 28, 2026 | Eylward Susan | General Counsel and Corp Sec | A · Grant/award | Direct | 2,525 | $1.60 | $4K | Form 4 |
| Aug 14, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 6,615 | $1.65 | $11K | Form 4 |
| Aug 14, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 7,147 | $1.65 | $12K | Form 4 |
| Aug 14, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 3,516 | $1.65 | $6K | Form 4 |
| Aug 17, 2026 | Eylward Susan | General Counsel and Corp Sec | S · Sale | Direct | 2,449 | $1.63 | $4K | Form 4 |
| Aug 14, 2026 | Eylward Susan | General Counsel and Corp Sec | A · Grant/award | Direct | 2,449 | $1.65 | $4K | Form 4 |
| Jul 31, 2026 | Pellizzari Christine A | Director | A · Grant/award | Direct | 6,934 | $1.59 | $11K | Form 4 |
| Jul 31, 2026 | Dentzer James E | Director | A · Grant/award | Direct | 6,934 | $1.59 | $11K | Form 4 |
| Jul 31, 2026 | Fritz Frederick J. | Director | A · Grant/award | Direct | 6,934 | $1.59 | $11K | Form 4 |
| Jul 31, 2026 | Braun Donald P | Director | A · Grant/award | Direct | 6,180 | $1.59 | $10K | Form 4 |
| Aug 3, 2026 | Eylward Susan | General Counsel and Corp Sec | S · Sale | Direct | 2,541 | $1.57 | $4K | Form 4 |
| Jul 31, 2026 | Eylward Susan | General Counsel and Corp Sec | A · Grant/award | Direct | 2,541 | $1.59 | $4K | Form 4 |
| Jul 31, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 6,358 | $1.59 | $10K | Form 4 |
| Jul 31, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 3,649 | $1.59 | $6K | Form 4 |
| Jul 31, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 5,010 | $1.59 | $8K | Form 4 |
| Jul 17, 2026 | Tardugno Michael H | Executive Chairman of Board | A · Grant/award | Direct | 4,603 | $1.83 | $8K | Form 4 |
| Jul 20, 2026 | Eylward Susan | General Counsel and Corp Sec | S · Sale | Direct | 2,150 | $1.78 | $4K | Form 4 |
| Jul 17, 2026 | Eylward Susan | General Counsel and Corp Sec | A · Grant/award | Direct | 2,150 | $1.83 | $4K | Form 4 |
| Jul 17, 2026 | Faller Douglas Vincent | Chief Medical Officer | A · Grant/award | Direct | 3,082 | $1.83 | $6K | Form 4 |
| Jul 17, 2026 | Lindborg Stacy | President and CEO | A · Grant/award | Direct | 4,907 | $1.83 | $9K | Form 4 |
IMNN insider trading FAQ
Are insiders buying IMNN stock?
Not on the open market. In the last 90 days, Imunon, Inc. insiders made no open-market purchases, and 4 open-market sales totaling $16K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading IMNN?
Recent sellers: Eylward Susan.
Where does IMNN insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.